Viridian Therapeutics, Inc.\DE (VRDN) Accumulated Depreciation & Amortization: 2014-2024
Historic Accumulated Depreciation & Amortization for Viridian Therapeutics, Inc.\DE (VRDN) over the last 8 years, with Dec 2024 value amounting to $1.3 million.
- Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization rose 20.69% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $4.4 million, marking a year-over-year increase of 39.68%. This contributed to the annual value of $540,000 for FY2024, which is 3.45% up from last year.
- Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization amounted to $1.3 million in Q4 2024, which was up 20.69% from $1.0 million recorded in Q4 2023.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization peaked at $2.0 million during Q4 2022, and registered a low of $25,000 during Q2 2021.
- In the last 3 years, Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization had a median value of $1.3 million in 2024 and averaged $1.4 million.
- Its Accumulated Depreciation & Amortization has fluctuated over the past 5 years, first plummeted by 60.94% in 2021, then skyrocketed by 6,162.50% in 2022.
- Quarterly analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Accumulated Depreciation & Amortization stood at $50,000 in 2020, then plummeted by 36.00% to $32,000 in 2021, then soared by 6,162.50% to $2.0 million in 2022, then crashed by 47.65% to $1.0 million in 2023, then increased by 20.69% to $1.3 million in 2024.
- Its last three reported values are $1.3 million in Q4 2024, $1.0 million for Q4 2023, and $2.0 million during Q4 2022.